{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:21:07Z","timestamp":1778052067083,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-026-05888-y","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:28:12Z","timestamp":1775575692000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of innovative financing to bridge the gap between implementation and commercialisation"],"prefix":"10.1186","volume":"25","author":[{"given":"Tristana","family":"Perez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Hein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karuna","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Di Mascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Vermeesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hutchins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"5888_CR1","doi-asserted-by":"crossref","unstructured":"Sun D, Gao W, Hu H, Zhou S. Why 90% of clinical drug development fails and how to improve it? Acta Pharmaceutica Sinica B. 2022;12(7) Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9293739\/","DOI":"10.1016\/j.apsb.2022.02.002"},{"key":"5888_CR2","unstructured":"European Medicines Agency. Mosquirix - European Medicines Agency European Medicines Agency. 2015. Available from: https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/mosquirix"},{"key":"5888_CR3","doi-asserted-by":"publisher","unstructured":"World Health Organization. Malaria vaccine: WHO position paper, January 2016 - Recommendations. Vaccine. 2018;36(25):3576-3577. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.047.","DOI":"10.1016\/j.vaccine.2016.10.047"},{"key":"5888_CR4","unstructured":"WHO. Malaria: The malaria vaccine implementation programme (MVIP) [Internet]. www.who.int. 2020. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/malaria-vaccine-implementation-programme"},{"key":"5888_CR5","unstructured":"Gavi and Global Fund statement on malaria vaccine recommendations [Internet]. www.gavi.org. 2015 [cited 2024 Jun 12]. Available from: https:\/\/www.gavi.org\/gavi-and-global-fund-statement-on-malaria-vaccine-recommendations"},{"key":"5888_CR6","unstructured":"Pneumococcal AMC [Internet]. www.gavi.org. Available from: https:\/\/www.gavi.org\/investing-gavi\/innovative-financing\/pneumococcal-amc"},{"key":"5888_CR7","unstructured":"Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks [Internet]. www.gavi.org. Available from: https:\/\/www.gavi.org\/news\/media-room\/ebola-vaccine-purchasing-commitment-gavi-prepare-future-outbreaks"},{"key":"5888_CR8","unstructured":"Mundy L. New financing agreement boost for malaria vaccine [Internet]. MedAccess. 2021 [cited 2024 Jun 12]. Available from: https:\/\/medaccess.org\/new-financing-agreement-boost-for-malaria-vaccine\/"},{"key":"5888_CR9","unstructured":"World Health Organization. WHO welcomes global health funding for malaria vaccine. World Health Organization. 2016;17."},{"key":"5888_CR10","unstructured":"Impact Framework [Internet]. MedAccess. [cited 2024 Jun 12]. Available from: https:\/\/medaccess.org\/why-we-exist\/development-impact-framework\/"},{"key":"5888_CR11","unstructured":"World Health Organization. WHO recommends groundbreaking malaria vaccine for children at risk [Internet]. www.who.int. 2021. Available from: https:\/\/www.who.int\/news\/item\/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk"},{"key":"5888_CR12","unstructured":"Gavi Board approves malaria vaccine programme funding, COVAX 2022 strategic approach and measures to maintain, restore and strengthen routine immunisation [Internet]. www.gavi.org. 2021 [cited 2024 Jun 12]. Available from: https:\/\/www.gavi.org\/news\/media-room\/gavi-board-approves-malaria-vaccine-programme-funding-covax-2022-strategic-approach."},{"key":"5888_CR13","unstructured":"RTS,S malaria vaccine [Internet]. MedAccess. [cited 2024 Jun 12]. Available from: https:\/\/medaccess.org\/our-agreements\/agreements\/rtss-malaria-vaccine\/."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-026-05888-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05888-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-026-05888-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:40:54Z","timestamp":1778049654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12936-026-05888-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5888"],"URL":"https:\/\/doi.org\/10.1186\/s12936-026-05888-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TP, RK, and JH are employed by MedAccess Guarantee Ltd.  DDM and AM are employed by and hold financial equities in GSK.  AV is a former employee and held financial equities in GSK during early development of this publication and is now employed by Gavi, the Vaccine Alliance.  KL and DH are employed by Gavi, the Vaccine Alliance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}